Cleveland-based Neuronoff develops and manufactures the investigational Injectrode, a needle-delivered neuromodulation device designed to make chronic-pain treatment less invasive than conventional implanted stimulators. Its system is placed through an 18-gauge needle, powered externally through the skin, and designed for straightforward removal; the company has completed its first-in-human LIFE study and reports Technology Readiness Level 7 for lower-back pain applications. Neuronoff manufactures in Cleveland under ISO 13485 and MDSAP-certified quality systems, while researching applications beyond pain care.
ISO 13485
MDSAP (Medical Device Single Audit Program)
ISO 14971 Risk Management Process
Compliance program